Bio-informatics approaches in liver disease: Incomplete without experimental validation

Pratibha Gaur*

In the search for the treatment of hepatic diseases, multiple approaches have been used frequently such as bioinformatics and algorithm-based systems biology for the screening of already published data that leads to the identification of promising drug candidates at molecular levels. These studies provide a large data set of information and claim to identify many genes, which could be targeted for the cure. However, it is important to note that the identified compounds are only predictions and the potential of these suggested molecules or genes should be well confirmed by adopting robust and critical experimental approaches to satisfy all possible aspects to use them safely for therapeutic purposes. Therefore, I put forward the opinion that these predicted markers whether prognostic, diagnostic, or molecular must be evaluated critically through a well-defined experimental pipeline.

Keywords:

Published on: Sep 27, 2022 Pages: 12-13

Full Text PDF Full Text HTML DOI: 10.17352/ahr.000033
CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat